RECRUITING

The Puerto Rico Asthma Integrated Response Program ("PR-AIR")

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to adapt and deliver an evidence-based multi-level intervention to reduce asthma disparities, and that promote and improve population health in the high-burden communities of San Juan, Puerto Rico. The Puerto Rico-Asthma Integrated Response Program (PR-AIR) will be implemented and evaluated to address pediatric asthma disparities in San Juan, PR, an area of high asthma burden. This study unfolds in two phases: In Phase 1, the researchers will collaborate with community stakeholders to identify needs, barriers and facilitators of PR-AIR implementation. Phase 2 consists of an evaluation of low-intensity (virtual) and high-intensity (in-person) methods of PR-AIR implementation outcomes using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework and a mixed methods approach.

Official Title

The Puerto Rico Asthma Integrated Response Program ("PR-AIR")

Quick Facts

Study Start:2024-12-16
Study Completion:2027-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05999032

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:2 Years to 12 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. 1. Children between the ages of 2 and 12 years old
  2. 2. Children must reside in one of the identified catchment areas
  3. 3. Children must meet the screening criteria as having not well controlled or poorly controlled asthma
  1. 1. Children with complex medical conditions

Contacts and Locations

Study Contact

Daphne Koinis Mitchell, PhD
CONTACT
401-793-8632
dkoinismitchell@lifespan.org
Elizabeth McQuaid, PhD, ABPP
CONTACT
401-444-7573
elizabeth_mcquaid@brown.edu

Principal Investigator

Daphne Koinis Mitchell, PhD
PRINCIPAL_INVESTIGATOR
Rhode Island Hospital
Elizabeth L McQuaid, PhD, ABPP
PRINCIPAL_INVESTIGATOR
Rhode Island Hospital
Ligia Chavez, PhD
PRINCIPAL_INVESTIGATOR
University of Puerto Rico

Study Locations (Sites)

Rhode Island Hospital
Providence, Rhode Island, 02903
United States

Collaborators and Investigators

Sponsor: Rhode Island Hospital

  • Daphne Koinis Mitchell, PhD, PRINCIPAL_INVESTIGATOR, Rhode Island Hospital
  • Elizabeth L McQuaid, PhD, ABPP, PRINCIPAL_INVESTIGATOR, Rhode Island Hospital
  • Ligia Chavez, PhD, PRINCIPAL_INVESTIGATOR, University of Puerto Rico

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-16
Study Completion Date2027-04-30

Study Record Updates

Study Start Date2024-12-16
Study Completion Date2027-04-30

Terms related to this study

Keywords Provided by Researchers

  • Pediatric asthma
  • Community intervention program
  • Hybrid Type III
  • Effectiveness and implementation
  • Home-based intervention
  • School-based intervention

Additional Relevant MeSH Terms

  • Pediatric Asthma